Leucovorin

thymidylate synthetase ; Homo sapiens







65 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 29324220 5-fluorouracil Toxicity Mechanism Determination in Human Keratinocytes: in vitro Study on HaCaT Cell Line. 2017 1
2 23494117 Enhancement of 5-fluorouracil-induced cytotoxicity by leucovorin in 5-fluorouracil-resistant gastric cancer cells with upregulated expression of thymidylate synthase. 2014 Jan 1
3 24093908 Targeting thymidylate synthase in colorectal cancer: critical re-evaluation and emerging therapeutic role of raltitrexed. 2014 Jan 1
4 25453619 Phase II clinical trial of S-1 plus oral leucovorin in previously treated patients with non-small-cell lung cancer. 2014 Dec 1
5 20567941 Severe toxicity of capecitabine following uncomplicated treatment with 5-fluorouracil/leucovorin. 2011 Dec 1
6 20647221 Associations of various gene polymorphisms with toxicity in colorectal cancer patients receiving oral uracil and tegafur plus leucovorin: a prospective study. 2011 Feb 2
7 20372793 The role of thymidine phosphorylase in the induction of early growth response protein-1 and thrombospondin-1 by 5-fluorouracil in human cancer carcinoma cells. 2010 May 3
8 15638735 Novel chemical strategies for thymidylate synthase inhibition. 2005 3
9 16077970 Thymidylate synthase expression levels: a prognostic and predictive role in advanced colorectal cancer. 2005 Sep 1
10 15025795 Dihydropyrimidine dehydrogenase and thymidylate synthase polymorphisms and their association with 5-fluorouracil/leucovorin chemotherapy in colorectal cancer. 2004 Feb 1
11 12610179 Thymidylate synthase protein expression in primary colorectal cancer: lack of correlation with outcome and response to fluorouracil in metastatic disease sites. 2003 Mar 1 3
12 12084461 Induction of thymidylate synthase as a 5-fluorouracil resistance mechanism. 2002 Jul 18 2
13 12422306 The role of oxaliplatin in the treatment of advanced metastatic colorectal cancer: prospects and future directions. 2002 Oct 1
14 12453856 Thymidylate synthase protein expression in colorectal cancer metastases predicts for clinical outcome to leucovorin-modulated bolus or infusional 5-fluorouracil but not methotrexate-modulated bolus 5-fluorouracil. 2002 Dec 1
15 11274973 Cytotoxic synergism of methioninase in combination with 5-fluorouracil and folinic acid. 2001 Apr 1 1
16 11283924 Phase II study of oral eniluracil, 5-fluorouracil, and leucovorin in patients with advanced colorectal carcinoma. 2001 Apr 1 1
17 12445371 Chemotherapeutic strategies for treatment of colorectal cancer: present and future developments. 2001 Aug 1
18 10097740 [Leucovorin and 5-FU for advanced gastrointestinal cancer]. 1999 Mar 2
19 10473077 Thymidylate synthase protein expression in advanced colon cancer: correlation with the site of metastasis and the clinical response to leucovorin-modulated bolus 5-fluorouracil. 1999 Aug 1
20 9596684 Increases in neutral, Mg2+-dependent and acidic, Mg2+-independent sphingomyelinase activities precede commitment to apoptosis and are not a consequence of caspase 3-like activity in Molt-4 cells in response to thymidylate synthase inhibition by GW1843. 1998 Jun 1 2
21 9663808 Clinically relevant drug-drug interactions in oncology. 1998 Jun 1
22 9726090 Thymidylate synthase as a predictor of response. 1998 Aug 1
23 9796967 High basal level gene expression of thymidine phosphorylase (platelet-derived endothelial cell growth factor) in colorectal tumors is associated with nonresponse to 5-fluorouracil. 1998 Oct 2
24 8996166 Thymidylate synthase inhibitors in cancer therapy: direct and indirect inhibitors. 1997 Jan 4
25 9223329 Thymineless death in colon carcinoma cells is mediated via fas signaling. 1997 Jul 22 1
26 9336359 Quantitation of intratumoral thymidylate synthase expression predicts for disseminated colorectal cancer response and resistance to protracted-infusion fluorouracil and weekly leucovorin. 1997 Oct 1
27 9620216 5-fluorouracil/leucovorin-induced inhibition of thymidylate synthase in normal tissues of mouse and man. 1997 3
28 8765432 Thymidylate synthase inhibition by an oral regimen consisting of tegafur-uracil (UFT) and low-dose leucovorin for patients with gastric cancer. 1996 2
29 9816097 Evaluation of irinotecan in combination with 5-fluorouracil or etoposide in xenograft models of colon adenocarcinoma and rhabdomyosarcoma. 1996 Jan 1
30 7574773 [Pharmacological and biochemical investigation of intracavital fluorinated pyrimidine chemotherapy]. 1995 Sep 1
31 7575641 Studies on the antitumor effects of analogues of 5,8-dideazaisofolic acid and 5,8-dideazaisoaminopterin. 1995 Sep 7 1
32 7577040 Thymidylate synthase and drug resistance. 1995 Jul-Aug 1
33 7577041 Quantitation of intratumoral thymidylate synthase expression predicts for resistance to protracted infusion of 5-fluorouracil and weekly leucovorin in disseminated colorectal cancers: preliminary report from an ongoing trial. 1995 Jul-Aug 1
34 7779703 The effect of dose and interval between 5-fluorouracil and leucovorin on the formation of thymidylate synthase ternary complex in human cancer cells. 1995 Jun 18
35 7805178 Phase I study of phosphonacetyl-L-aspartate, 5-fluorouracil, and leucovorin in patients with advanced cancer. 1995 2
36 7882343 Thymidylate synthase gene and protein expression correlate and are associated with response to 5-fluorouracil in human colorectal and gastric tumors. 1995 Apr 1 2
37 7518280 New targets for pyrimidine antimetabolites in the treatment of solid tumours. 1: Thymidylate synthase. 1994 Apr 15 1
38 7872700 Thymidylate synthase levels in tumor biopsies from patients with colorectal cancer. 1994 Nov-Dec 2
39 7931471 Thymidylate synthase inhibition after administration of fluorouracil with or without leucovorin in colon cancer patients: implications for treatment with fluorouracil. 1994 Oct 1
40 8053928 Down-regulation of c-myc gene expression with induction of high molecular weight DNA fragments by fluorodeoxyuridine. 1994 Jul 19 1
41 8141112 Phase II trial of 5-fluorouracil and high-dose folinic acid as first- or second-line therapy for advanced breast cancer. 1994 Apr 1
42 8178733 Comparison of continuous infusions and bolus injections of 5-fluorouracil with or without leucovorin: implications for inhibition of thymidylate synthase. 1993 1
43 8304192 Potentiation of 5-fluorouracil induced inhibition of thymidylate synthase in human colon tumors by leucovorin is dose dependent. 1993 1
44 8398636 Leucovorin modulation of fluorouracil. 1993 Aug 1
45 8400344 Immunological quantitation of thymidylate synthase-FdUMP-5,10-methylenetetrahydrofolate ternary complex with the monoclonal antibody TS 106. 1993 Aug 1
46 8461049 Effect of folate diastereoisomers on the binding of 5-fluoro-2'-deoxyuridine-5'-monophosphate to thymidylate synthase. 1993 Mar 9 2
47 8500227 Phase I trial of a 5-day infusion of L-leucovorin plus daily bolus 5-fluorouracil in patients with advanced gastrointestinal malignancies. 1993 1
48 1327567 In vitro enhancement of fluoropyrimidine-induced cytotoxicity by leucovorin in colorectal and gastric carcinoma cell lines but not in non-small-cell lung carcinoma cell lines. 1992 2
49 1557655 Time course of inhibition of thymidylate synthase in patients treated with fluorouracil and leucovorin. 1992 Apr 1
50 1596583 Quantitation of dihydrofolate reductase and thymidylate synthase mRNAs in vivo and in vitro by polymerase chain reaction. 1992 2